Article: Adding elotuzumab to standard treatment for multiple myeloma delays disease progression

€3.03

SKU: product-article-18799 Category: General

Description

Description

Adding elotuzumab to standard treatment for multiple myeloma delays disease progression

Top

Article: Adding elotuzumab to standard treatment for multiple myeloma delays disease progression

Description

Related products

Article: INTRODUCTION

Article: Highlights in urologic cancer

Article: Highlights in squamous cell carcinoma of the head and neck

1 year subscription print edition of the Belgian Journal of Hematology (BJH)